An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
Open Access
- 1 January 2013
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 2 (1) , e22409
Abstract
One of the driving forces of oncogenesis is tetraploidy, a duplication of the DNA content that, upon asymmetric cell division or progressive chromosome loss, can originate aneuploidy. Recent findin...Keywords
This publication has 13 references indexed in Scilit:
- An Immunosurveillance Mechanism Controls Cancer Cell PloidyScience, 2012
- The Causes and Consequences of Polyploidy in Normal Development and CancerAnnual Review of Cell and Developmental Biology, 2011
- Mitotic catastrophe: a mechanism for avoiding genomic instabilityNature Reviews Molecular Cell Biology, 2011
- Illicit survival of cancer cells during polyploidization and depolyploidizationCell Death & Differentiation, 2010
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumorsNature Medicine, 2009
- Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell deathThe EMBO Journal, 2009
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Tetraploidy, aneuploidy and cancerCurrent Opinion in Genetics & Development, 2007
- Calreticulin exposure dictates the immunogenicity of cancer cell deathNature Medicine, 2006
- Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cellsNature, 2005